Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AMPE | F | Ampio Pharmaceuticals, Inc. | -11.76 | |
IFRX | F | InflaRx N.V. | -6.16 | |
ATRA | F | Atara Biotherapeutics, Inc. | -6.00 | |
PULM | D | Pulmatrix, Inc. | -5.10 | |
SAGE | F | Sage Therapeutics, Inc. | -4.95 | |
SLRX | F | Salarius Pharmaceuticals, Inc. | -3.99 | |
NVAX | D | Novavax, Inc. | -3.45 | |
VCNX | F | Vaccinex, Inc. | -3.31 | |
GMED | F | Globus Medical, Inc. | -3.23 | |
CPIX | F | Cumberland Pharmaceuticals Inc. | -3.16 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
TMFM | B | Motley Fool Mid-Cap Growth ETF | 3.99 | |
TMFS | A | Motley Fool Small-Cap Growth ETF | 3.66 | |
PSIL | F | AdvisorShares Psychedelics ETF | 2.89 | |
EKG | C | First Trust Nasdaq Lux Digital Health Solutions ETF | 2.74 | |
LABD | D | Direxion Daily S&P Biotech Bear 3X Shares | 2.21 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles